BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9469239)

  • 1. Neurocognitive correlates of positive and negative syndromes in schizophrenia.
    Voruganti LN; Heslegrave RJ; Awad AG
    Can J Psychiatry; 1997 Dec; 42(10):1066-71. PubMed ID: 9469239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive deficits and neurological signs in schizophrenia.
    Wong AH; Voruganti LN; Heslegrave RJ; Awad AG
    Schizophr Res; 1997 Feb; 23(2):139-46. PubMed ID: 9061810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive profile and its association with psychopathology in first-degree relatives of patients with schizophrenia. a case-control study.
    Scala S; Lasalvia A; Cristofalo D; Bonetto C; Ruggeri M
    Psychiatry Res; 2012 Dec; 200(2-3):137-43. PubMed ID: 22652345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis.
    Mahurin RK; Velligan DI; Miller AL
    Psychiatry Res; 1998 Jun; 79(2):139-49. PubMed ID: 9705052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia.
    Mattson DT; Berk M; Lucas MD
    J Genet Psychol; 1997 Dec; 158(4):487-94. PubMed ID: 9423278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight, neurocognitive function and symptom clusters in chronic schizophrenia.
    Collins AA; Remington GJ; Coulter K; Birkett K
    Schizophr Res; 1997 Oct; 27(1):37-44. PubMed ID: 9373893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia.
    Woon PS; Chia MY; Chan WY; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):463-8. PubMed ID: 20109511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of neurocognition between drug-free patients with schizophrenia and bipolar disorder.
    Tam WC; Liu Z
    J Nerv Ment Dis; 2004 Jul; 192(7):464-70. PubMed ID: 15232316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive functioning as an intermediary variable between psychopathology and insight in schizophrenia.
    Hwang SS; Ahn YM; Kim YS
    Psychiatry Res; 2015 Dec; 230(3):792-9. PubMed ID: 26602231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia.
    Heslegrave RJ; Awad AG; Voruganti LN
    J Psychiatry Neurosci; 1997 Jul; 22(4):235-43. PubMed ID: 9262045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficit measures in schizophrenia: factor structure and clinical correlates.
    Lieh-Mak F; Lee PW
    Am J Psychiatry; 1997 Jun; 154(6 Suppl):39-46. PubMed ID: 9167543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Card-sort performance and syndromes of schizophrenia.
    Rowe EW; Shean G
    Genet Soc Gen Psychol Monogr; 1997 May; 123(2):197-209. PubMed ID: 9204545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia.
    Zhou FC; Xiang YT; Wang CY; Dickerson F; Au RW; Zhou JJ; Zhou Y; Shum DH; Chiu HF; Man D; Lee EH; Yu X; Chan RC; Ungvari GS
    Schizophr Res; 2012 Mar; 135(1-3):34-9. PubMed ID: 22222379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopathology and Wisconsin Card Sorting Test performance in male schizophrenic patients: influence of dual diagnosis.
    Rodriguez-Jimenez R; Aragües M; Jimenez-Arriero MA; Ponce G; Martinez I; Hoenicka J; Rubio G; Palomo T;
    Psychopathology; 2008; 41(1):58-64. PubMed ID: 17975329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
    Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
    J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between negative symptoms and neurocognitive functions in adolescent and adult patients with first-episode schizophrenia.
    Huang M; Huang Y; Yu L; Hu J; Chen J; Jin P; Xu W; Wei N; Hu S; Qi H; Xu Y
    BMC Psychiatry; 2016 Oct; 16(1):344. PubMed ID: 27716115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.